Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin with Carboplatin and Paclitaxel in Metastatic Nasopharyngeal Carcinoma
NCT02250599Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2014
- Primary completion
- Apr 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02250599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02250599.